Disclosures for "CNS Drugs Targeting the Neuropsychiatric and Cognitive Symptoms of Alzheimer’s Disease"
-
The institution of Mr. Butler has received research support from American Academy of Neurology.
-
The institution of Dr. Hunsberger has received research support from Ataraxia LLC.
-
Mr. Kaplan has nothing to disclose.
-
Mrs. Toennies has nothing to disclose.
-
Dr. Stutzmann has nothing to disclose.
-
Dr. Gupta has nothing to disclose.
-
Dr. Steinbrenner has nothing to disclose.
-
Mrs. Webber has nothing to disclose.